Why is JFL Life falling/rising?

As of 23-Sep, JFL Life Sciences Ltd is currently priced at 13.30, showing no change (0.00%). The stock has underperformed in the short term, with a 1-week return of -0.75% and a 1-month return of -1.12%. Despite a slight outperformance against its sector today by 0.35%, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. While the company has demonstrated healthy long-term growth with an annual operating profit increase of 34.76% and a return on capital employed (ROCE) of 14.4, the stock has suffered a significant decline of -80.06% over the past year, despite a 26% rise in profits. Additionally, the recent flat results in net sales, which fell by -27.8% compared to the previous quarter average, contribute to the stock's negative sentiment.
In the broader market context, JFL Life's performance contrasts sharply with the Sensex, which has shown a positive return of +1.20% over the past month and +6.45% year-to-date. The stock's significant underperformance over the year (-80.06%) and three years (-73.64%) compared to the benchmark's gains indicates a lack of investor confidence, despite rising investor participation reflected in a 25% increase in delivery volume. This juxtaposition highlights the challenges JFL Life faces in regaining market traction amidst a generally positive market environment.